Follow the people · Insider
Christian Heidbreder
Christian Heidbreder files insider transactions with the SEC as a chief scientific officer of Indivior Pharmaceuticals (INDV). We hold 2 disclosed purchases and sales filed since 12 February 2026, 2 of them in the last 90 days.
- Files forINDV
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure13 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 9 February 2026 — 10 July 2026Chief Scientific Officer · Indivior Pharmaceuticals (INDV)12 Form 4 lines · source: SEC Form 4
Everything they disclosed
12 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 18,586 shares of Indivior PharmaceuticalsSEC Form 413 July 2026Common Stock · traded 10 July 2026 · filed 13 July 2026
- ▼ sold on the open market 18,586 shares of Indivior PharmaceuticalsSEC Form 412 June 2026Common Stock · traded 11 June 2026 · filed 12 June 2026
- exercised options over 101,544 shares of Indivior PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 45,797 shares of Indivior PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 132,565 shares of Indivior Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Performance Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 132,565 shares of Indivior Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Performance Stock Units · traded 3 March 2026 · filed 5 March 2026
- exercised options over 101,544 shares of Indivior PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- had shares withheld for tax on 45,797 shares of Indivior PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- was granted 33,622 shares of Indivior PharmaceuticalsSEC Form 412 February 2026Common Stock · traded 10 February 2026 · filed 12 February 2026
- was granted 132,565 shares of Indivior Pharmaceuticals (a derivative holding)SEC Form 412 February 2026Performance Stock Units · traded 9 February 2026 · filed 12 February 2026
- was granted 132,565 shares of Indivior Pharmaceuticals (a derivative holding)SEC Form 412 February 2026Performance Stock Units · traded 9 February 2026 · filed 12 February 2026
- was granted 33,622 shares of Indivior PharmaceuticalsSEC Form 412 February 2026Common Stock · traded 10 February 2026 · filed 12 February 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.